2.48 USD
↗ 0.10 (4.20%)PRE MARKET (AS OF 07:23 AM EDT)
Chemomab Therapeutics Ltd. American Depositary Share
CMMBNASDAQ • USD
Market: OPEN
CMMB is currently priced at $2.48. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9 and a bullish Golden Cross on the moving averages.
Technical & fundamental data as of Sep 22, 2026.
Open?$2.47
High?$2.80
Low?$2.33
Prev. Close?$2.38
Volume?473
Avg. Volume?N/A
VWAP?$2.49
Bid / Ask
Bid?$2.03 × 100
Ask?$2.97 × 100
Spread?$0.94
Midpoint?$2.50
Valuation & Ratios
Market Cap?18.2M
Shares Out?7.2M
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Chemomab Therapeutics Ltd is a clinical-stage biotechnology company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases.
Employees
12
Market Cap
18.2M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2021-03-17
Address
KIRYAT ATIDIM, BUILDING 7
TEL AVIV, L3 6158002
Phone: 972-77-331-0156
TEL AVIV, L3 6158002
Phone: 972-77-331-0156
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?58
Piotroski F-Score?0/9Weak
Altman Z-Score?-11.35Distress
Confidence?48%Low
Short InterestLow
Short Interest?102.7K
Days to Cover?1.0
Avg Daily Volume139.8K
Settlement Date2026-08-31